IMPACT (Improving Patient Access to Cancer Testing) grant program supports patient advocacy organizations’ work to improve access to genomic testing and help people affected by cancer understand their results.
Medical Education Grants - Illumina support independent medical educators in teaching about genomics in prenatal care, rare disease, and cancer to strengthen precision medicine and improve patient care.
Illumina and Optum Genomics Clinical Catalyst Program supports developers of emerging genomic tests with clinical evidence assessment and access planning to help bring promising applications into patient care.
Medical Sponsorships - Illumina supports organizations’ philanthropic, educational, and scientific causes and events connected to genomics, furthering Illumina’s mission to unlock the power of the genome.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
Epigenetics Research Grant supports basic scientists with DNA methylation research supplies to advance understanding of how epigenetics affects biology, human health, and disease.